Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (α/γ) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study
- David M. Kendall
- , Cindy J. Rubin
- , Pharis Mohideen
- , Jean Marie Ledeine
- , Rene Belder
- , Jorge Gross
- , Paul Norwood
- , Michael O'Mahony
- , Kenneth Sall
- , Greg Sloan
- , Anthony Roberts
- , Fred T. Fiedorek
- , Ralph A. DeFronzo
Producción científica: Article › revisión exhaustiva
139
El enlace se abre en una pestaña nueva
Citas
(Scopus)